Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.8
-84.14%
40%
—
53.86%
60%
—
5 Years
Score3.8
Net Growth-84.14%
Net Trend40%
Net Income Consistency—
Rev Growth53.86%
Rev Trend60%
Revenue Consistency—
Tango Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 7M to $ 62M and net income went from -$ 51M to -$ 101M. Revenue increased in 3 of those 5 years; net income in 2.
Tango Therapeutics Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 25.58 | — |
1 Year2025-08-12 | $ 6.76 | 278.40% |
5 Years2021-08-12 | $ 9.56 | 167.57% |
All Time2020-09-03 | $ 10.23 | 150.05% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-09-03 |
|---|---|---|---|---|
| Price | $ 25.58 | $ 6.76 | $ 9.56 | $ 10.23 |
| Return | — | 278.40% | 167.57% | 150.05% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 56M | -$ 107M | $ 379M |
| 2025 | $ 62M | -$ 101M | $ 343M |
| 2024 | $ 42M | -$ 130M | $ 257M |
| 2023 | $ 36M | -$ 101M | $ 336M |
| 2022 | $ 24M | -$ 108M | $ 366M |
| 2021 | $ 37M | -$ 58M | $ 485M |
| IPO2020 | $ 7M | -$ 51M | $ 190M |
Explore beyond TNGX
You're looking at Tango Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
